[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0111726A - Derivados de biotina - Google Patents

Derivados de biotina

Info

Publication number
BR0111726A
BR0111726A BR0111726-2A BR0111726A BR0111726A BR 0111726 A BR0111726 A BR 0111726A BR 0111726 A BR0111726 A BR 0111726A BR 0111726 A BR0111726 A BR 0111726A
Authority
BR
Brazil
Prior art keywords
biotin derivatives
body fluids
extracorporeal
toxic material
mammalian
Prior art date
Application number
BR0111726-2A
Other languages
English (en)
Inventor
Bengt Sandberg
Scott Wilbur
Rune Nilsson
Original Assignee
Mitra Medical Technology Ab
Dept Of Radiation Oncology Uni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002287A external-priority patent/SE0002287D0/xx
Application filed by Mitra Medical Technology Ab, Dept Of Radiation Oncology Uni filed Critical Mitra Medical Technology Ab
Publication of BR0111726A publication Critical patent/BR0111726A/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"DERIVADOS DE BIOTINA". Um método para o condicionamento de um dispositivo extracorpóreo é descrito, bem como método para extração extracorpórea de material tóxico de fluidos de corpo de mamífero com relação a diagnose ou tratamento de uma condição ou doença de mamífero, em cujos métodos reagentes tendo a capacidade de extrair material tóxico de fluidos de corpo de mamífero são envolvidos, e um dispositivo extracorpóreo compreendendo o referido reagente.
BR0111726-2A 2000-06-16 2001-06-18 Derivados de biotina BR0111726A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002287A SE0002287D0 (sv) 2000-06-16 2000-06-16 Biotinderivat
US21662500P 2000-07-07 2000-07-07
PCT/SE2001/001374 WO2001095857A2 (en) 2000-06-16 2001-06-18 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates

Publications (1)

Publication Number Publication Date
BR0111726A true BR0111726A (pt) 2003-05-27

Family

ID=26655149

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111726-2A BR0111726A (pt) 2000-06-16 2001-06-18 Derivados de biotina

Country Status (14)

Country Link
EP (1) EP1289563B1 (pt)
JP (1) JP2004503299A (pt)
CN (1) CN1457260A (pt)
AT (1) ATE469661T1 (pt)
AU (2) AU7476101A (pt)
BR (1) BR0111726A (pt)
CA (1) CA2412495C (pt)
DE (1) DE60142286D1 (pt)
HU (1) HUP0401953A3 (pt)
IL (1) IL153449A0 (pt)
MX (1) MXPA02012438A (pt)
NO (1) NO20025931L (pt)
PL (1) PL359328A1 (pt)
WO (1) WO2001095857A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1813614T3 (pl) * 2006-01-25 2012-03-30 Sanofi Sa Środki cytotoksyczne zawierające nowe pochodne tomaymycyny
CA2705334C (en) * 2007-11-12 2018-04-17 Novozymes A/S Dual affinity polypeptides for purification
KR102179369B1 (ko) * 2011-05-27 2020-11-16 암브룩스, 인코포레이티드 비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
SG195183A1 (en) * 2011-05-27 2013-12-30 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
CN106459089B (zh) * 2014-02-18 2021-01-08 赛威德医疗公司 生物素变体、链霉亲和素突变体以及它们的应用
CN106166311B (zh) * 2016-08-30 2018-07-13 张小曦 一种血浆净化系统及其应用
BR112019011304A2 (pt) * 2016-12-27 2019-10-15 Hoffmann La Roche anticorpo monoclonal, método de medição de substâncias a analisar em amostras, uso, kit de teste de imunoensaio, imunogene da fórmula i e métodos de produção de anticorpos
WO2018122205A2 (en) 2016-12-27 2018-07-05 F. Hoffmann-La Roche Ag Novel biotin-specific monoclonal antibody and use thereof
US11442066B2 (en) 2017-02-17 2022-09-13 Mitsui Chemicals, Inc Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
JP3441530B2 (ja) * 1994-10-03 2003-09-02 株式会社セルシード 温度応答型分離材料及びその製造方法
JP3300583B2 (ja) * 1995-11-10 2002-07-08 幹男 中山 抗原又は抗体の検出シート、検出キット及び検出方法
WO1997029114A1 (en) * 1996-02-08 1997-08-14 Board Of Regents Of The University Of Washington Biotin-containing compounds, biotinylation reagents and methods

Also Published As

Publication number Publication date
CA2412495A1 (en) 2001-12-20
HUP0401953A3 (en) 2005-06-28
CA2412495C (en) 2011-02-01
AU2001274761B2 (en) 2005-06-16
JP2004503299A (ja) 2004-02-05
WO2001095857A2 (en) 2001-12-20
NO20025931L (no) 2003-02-14
AU7476101A (en) 2001-12-24
DE60142286D1 (de) 2010-07-15
EP1289563B1 (en) 2010-06-02
IL153449A0 (en) 2003-07-06
NO20025931D0 (no) 2002-12-11
MXPA02012438A (es) 2004-09-06
HUP0401953A2 (hu) 2004-12-28
ATE469661T1 (de) 2010-06-15
EP1289563A2 (en) 2003-03-12
PL359328A1 (en) 2004-08-23
CN1457260A (zh) 2003-11-19
WO2001095857A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
BRPI0515758A (pt) dispositivo de ensaio de diagnóstico
BR0112602A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
ATE440629T1 (de) Kanüleneinführungssystem
BR9916020A (pt) Compostos e métodos para o tratamento e diagnóstico de infecção por chlamydia
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
BR0316111A (pt) Métodos para diagnosticar rcc e outros tumores sólidos
BRPI0413350A (pt) dispositivo e métodos para coleta de amostra de fluido biológico e tratamento de componentes selecionados
EP1855719A4 (en) NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME
AU7494701A (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
BR9815866A (pt) Dispositivo para a coleta e preparação inicial de amostras de células contendo dna, processos para a coleta de uma amostra de células contendo dna e para a tipificação de populações animais e uso do dispositivo
BR0111726A (pt) Derivados de biotina
DE50207866D1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
SE0002287D0 (sv) Biotinderivat
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
WO2003001182A3 (en) Homocysteinylated transthyretin
PT1242825E (pt) Extraccao de lipoproteinas a partir de fluidos corporais
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
DE60037676D1 (de) Verfahren zur diagnose von rickettsia pulicis
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
WO2003061622A3 (de) Verfahren und vorrichtumg tum einbringen von lebenden zellen in eine biologische körperflüssigkeit
DE60144027D1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
ATE151816T1 (de) Nachweis synthetischer oligonucleotide extrahiert aus körperflüssigkeiten oder geweben:
DE69934236D1 (de) Proteoglykan (azaftig) zur überwachung von kachexie und zur fettleibigkeitskontrolle

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.

B15K Others concerning applications: alteration of classification

Ipc: B01D 15/38 (2006.01)